Moran, Meilig

Moran, Meilig was paid $162K by Medicaid between Jul 2019 and May 2023, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.

33Billing provider infoMORAN, MEILIG
MIDDLETOWN, NY 10941

33aNPI1831655026assigned 02/13/2019

33bProvider typeFamily Nurse Practitioner

28Total paid$162K

24GClaims1,346

24DCodes billed7

24AFirst – last monthJul 2019 – May 2023

Compared with peers

Next to other Family Nurse Practitioner providers in New York

Rank by total paid#65 of 1,582

Median peer was paid$2K

This provider vs. median70×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	61	$7K
2020	245	$25K
2021	332	$43K
2022	581	$76K
2023	127	$11K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	30%	409	404	$49K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	27%	317	315	$44K
S9083	Global fee urgent care centers	23%	244	243	$37K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	260	254	$24K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	4.2%	74	74	$7K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	25	25	$666.71
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	17	17	$421.25

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.